12 Oral Tongue Cancer

250 Oral Tongue Cancer

12 References

1. Akine Y et al. Stage I-II carcinoma of the anterior two-thirds of the tongue treated with different modalities: a retrospective analysis of 244 patients. Radiother Oncol 1991; 21 : 24-8. 2. Benk V, Mazeron JJ, Grimard J, et al. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol 1990; 18 : 229-47. 3. Bolla M, Elbaze D, Barthelme, et al. Exclusive irradiation of carcinomas of the oral tongue and floor of mouth. Results about 457 cases . J Eur Radiother 1983; 4 : 64-73. 4. Chu A, Fletcher GH. Incidence and causes of failure to control by irradiation the primary lesion in squamous cell carcinomas of the anterior two thirds of the tongue and floor of mouth. Am J Roengenol 1973; 117 : 502-8. 5. Decroix Y, Ghossein NA. Experience of the Curie Institute in the treatment of cancer of the mobile tongue. Cancer 1981; 47 : 496-502. 6. Fujita M, Hirokawa Y, Kashiwado K, et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys 1999; 44 : 767-75. 7. Gerbaulet A, Haie-Meder C, Marsiglia H, et al. Role of brachytherapy in the treatment of Head & Neck cancer. Selectron Brachy J , 1992; 3 : 15-20. 8. Gerbaulet A, Maher M. Brachytherapy in the treatment of head and neck cancer. In Joslin CAF, Flynn A, Hall EJ (eds.) Principles and practice of brachytherapy . London: Arnold, 2001; 284-95. 9. Haie-Meder C, Marsiglia H, Mamelle G, et al. Curiethérapie de carcinomes épidermoïdes de la cavité buccale. Bull Cancer Radiother 1995; 82 : 186-90. 10. Hareyama M, Nishio M, Saito A, et al. Results of cesium needle interstitial implantation for carcinoma of the oral tongue. Int J Radiat Oncol Biol Phys 1992; 25 : 29-34. 11. Inoue T, Teshima T, et al.: Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys 1996; 36 : 1201-4. 12. Lapeyre M, Hoffstetter S, Peiffert D, et al. Postoperative brachytherapy alone for T1-2 No squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys 2000; 48 : 37-42. 13. Lau HY, Hay JH, Flores AD, et al.: Seven fractions of twice daily high dose-rate brachytherapy for node negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 1996; 39 : 19-29. 14. Lefebvre JL, Coche-Dequeant B, Buisset E, et al. Management of early oral cavity cancer. Experience of Centre Oscar Lambret Eur J Cancer 1994; 30B : 216-20. 15. Mahe M, De Laroche G, Romestaing P, et al. An original technique of brachytherapy for T1 T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1993; 25 : 513-6. 16. Mazeron JJ, Crook JM, Marinello G, et al. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation. Radiother Oncol 1990; 19 : 281-5. 17. Mazeron JJ, Crook JM, Benck, et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990; 19 : 1369-76. 18. Mazeron JJ, Simon JM, LePechoux C, et al. Effect of dose rate on local control and complications in definitive irradiation of T1 to 2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium 192. Radiother Oncol 1991; 21 : 39-47. 19. Mazeron JJ, Gerbaulet A. A propos d’un échec de la curiethérapie interstitielle exclusive à haut débit des carcinomes épidermoïdes de la langue mobile. Bull Cancer Radiother 1996; 83 : 172-3. 20. Mazeron JJ, Gerbaulet A, Simon JM, Hardiman C. How to optimize therapeutic ratio in brachytherapy of head and neck squamous cell carcinoma? Acta Oncol 1998; 37 (6) : 583-91.